Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics has released a video interview with CEO Doug Ward, discussing their first positive cashflow generation quarter and the successful launch of diagnostic products FebriDx and ViraDx in the US and Europe. The company, a pioneer in rapid point-of-care diagnostic technologies, also outlined its commercial strategies following recent distribution agreements and highlighted potential future revenue streams.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
